NIC co-founder Tony Mullen, heart attack victim, mourned by former colleagues … Nursing home staff, families complain about major problems with Georgia’s online and phone complaint services...
NIH: Inhaled moisturizing drug boosts lung function in severe COPD
By
Alicia Lasek
Feb 02, 2021
The biologic drug hyaluronan improved lung function in patients hospitalized for severe exacerbation of chronic obstructive pulmonary disease, a new study finds.
Poor sleep linked to more COPD flare-ups: NIH study
By
Alicia Lasek (f3)
Jun 07, 2022
Poor sleep quality is a good predictor of whether a patient with COPD will have exacerbations, researchers say.
Essential steps for treating those with COPD
By
John W. Walsh
Mar 05, 2014
Chronic obstructive pulmonary disease (COPD) is a progressive, presently incurable respiratory illness that is characterized by airflow obstruction. For long-term care professionals, knowledge about every...
Clinical Briefs for Wednesday, June 26
By
Alicia Lasek
Jun 25, 2019
Drug combo may combat deadly candida auris … Alzheimer’s ‘cabal’ thwarted research progress for decades … Can deprescribing drugs reduce dementia risk? … NIH study: Optimal threshold for diagnosing...
Clinical briefs for Tuesday, May 25
By
Alicia Lasek
May 25, 2021
State ALA argues for continuing the broadened scope of nursing practices after pandemic … Pulmonary rehab not easily accessible for many older adults with COPD … ‘Complete revision’ of body mass...
Patent received for COPD medication
May 10, 2017
Pulmatrix Inc., a biopharmaceutical company, said Tuesday it had received a patent for its drug PUR0200, which is designed to treated chronic obstructive pulmonary diseases (COPD).
Simple finger prick helps gauge need for antibiotics during COPD flare
By
Alicia Lasek
Jul 12, 2019
A finger-prick blood test could help prevent overuse of antibiotics for COPD flares. What’s more, the approach is safe for patients, researchers say.
In-home COPD management program cuts 30-day acute-care readmissions
By
Alicia Lasek (f3)
Jun 29, 2022
Thirty-day readmission rates were 12% for post-acute COPD participants in an at-home pulmonary rehab program, and 22% for those without the intervention, a new study finds.